Aptevo Therapeutics Inc. (APVO) Stock: New Financing Targets $4.5M in Gross Proceeds

TLDR Aptevo targets $4.5 million through warrant exercises and a private placement. Existing warrant holders will exercise up to 254,922 shares at $4.03 per share. The PIPE offers up to 861,708 shares plus warrants covering 4.3 million shares. Aptevo expects both financing transactions to close around August 13, 2026. Net proceeds will support working capital [...]

The post Aptevo Therapeutics Inc. (APVO) Stock: New Financing Targets $4.5M in Gross Proceeds appeared first on Blockonomi.